Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
26.28
-0.56 (-2.09%)
At close: Mar 9, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.64 billion as of March 9, 2026. Its market cap has increased by 5.16% in one year.
Market Cap
9.64B
Enterprise Value
8.37B
Revenue
230.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.28
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.64B, a decrease of -22.75%. That is a compound annual growth rate of -9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.84B | -1.47% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 10.10B |
| Bio-Thera Solutions | 9.37B |
| Aurisco Pharmaceutical | 10.37B |
| Liaoning Chengda Biotechnology | 10.39B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.66B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| HitGen | 10.83B |
| Chengzhi | 10.85B |